Identification of potential micro-messenger RNAs (miRNA–mRNA) interaction network of osteosarcoma

References

• Han Q, Yang J, Yang H, et al. KIAA1429 promotes osteosarcoma progression by promoting stem cell properties and is regulated by miR-143-3p. Cell Cycle (Georgetown, Tex). 2020;19(10):1172–1185.
   PubMed Web of Science ®Google Scholar
• Hou Y, Feng H, Jiao J, et al. Mechanism of miR-143-3p inhibiting proliferation, migration and invasion of osteosarcoma cells by targeting MAPK7. Artif Cells Nanomed Biotechnol. 2019;47(1):2065–2071.
   PubMed Web of Science ®Google Scholar
• Meng CY, Zhao ZQ, Bai R, et al. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway. Oncol Rep. 2020;43(4):1169–1186.
   PubMed Web of Science ®Google Scholar
• Hirahata M, Osaki M, Kanda Y, et al. PAI −1, a target gene of miR-143, regulates invasion and metastasis by upregulating MMP-13 expression of human osteosarcoma. Cancer Med. 2016;5(5):892–902.
   PubMed Web of Science ®Google Scholar
• Zhu T, Fan D, Ye K, et al. Role of miRNA-542-5p in the tumorigenesis of osteosarcoma. FEBS Open Bio. 2020;10(4):627–636.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li Z, Ji W, et al. Influence mechanism of miRNA-144 on proliferation and apoptosis of osteosarcoma cells. Oncol Lett. 2020;19(2):1530–1536.
   PubMed Web of Science ®Google Scholar
• Zhao X, Xu Y, Sun X, et al. miR-17-5p promotes proliferation and epithelial-mesenchymal transition in human osteosarcoma cells by targeting SRC kinase signaling inhibitor 1. J Cell Biochem. 2019;120(4):5495–5504.
   PubMed Web of Science ®Google Scholar
• Hu W, Yao W, Li H, et al. MiR-30e-5p inhibits the migration and invasion of nasopharyngeal carcinoma via regulating the expression of MTA1. Biosci Rep. 2020;40(5):BSR20194309.
   Google Scholar
• Chen B, Zheng ZY, Yang JZ, et al. MicroRNA-191-5p promotes the development of osteosarcoma via targeting EGR1 and activating the PI3K/AKT signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23(9):3611–3620.
   PubMed Web of Science ®Google Scholar
• Ouyang L, Liu P, Yang S, et al. A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma. Med Oncol. 2013;30(1):340.
   PubMed Web of Science ®Google Scholar
• Nakka M, Allen-Rhoades W, Li Y, et al. Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma. Oncotarget. 2017;8(57):96738–96752.
   PubMedGoogle Scholar
• Gao F, Tian J, Liu XD, et al. MicroRNA-145 expression in the plasma of patients with benign and malignant bone tumors and its effects on osteosarcoma cell proliferation and migration. Panminerva Med. 2016;58(2):103–108.
   PubMed Web of Science ®Google Scholar
• Tao Z, Shi A, Li R, et al. Microarray bioinformatics in cancer- a review. J BUON. 2017;22:838–843.
   PubMed Web of Science ®Google Scholar
• Fonseka P, Pathan M, Chitti SV, et al. FunRich enables enrichment analysis of OMICs datasets. J Mol Biol. 2021;433(11):166747.
   PubMed Web of Science ®Google Scholar
• Doncheva NT, Morris JH, Gorodkin J, et al. Cytoscape stringapp: Network analysis and visualization of proteomics data. J Proteome Res. 2019;18(2):623–632.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Franceschini A, Wyder S, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(D1):D447–52.
   PubMed Web of Science ®Google Scholar
• Liao S, Xing S, Ma Y. LncRNA SNHG16 sponges miR-98-5p to regulate cellular processes in osteosarcoma. Cancer Chemother Pharmacol. 2019;83(6):1065–1074.
   PubMed Web of Science ®Google Scholar
• Zhu G, Liu X, Su Y, et al. Knockdown of Urothelial Carcinoma-Associated 1 Suppressed Cell Growth and Migration Through Regulating miR-301a and CXCR4 in Osteosarcoma MHCC97 Cells. Oncol Res. 2018;27(1):55–64.
   PubMed Web of Science ®Google Scholar
• Ni Z, Shang XF, Wang YF, et al. Upregulated microRNA-301a in osteosarcoma promotes tumor progression by targeting CDC14A. Genet Mol Res: 15(2):gmr7807.
   Web of Science ®Google Scholar
• Kawano M, Tanaka K, Itonaga I, et al. MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing’s sarcoma cells. Int J Oncol. 2016;48(4):1531–1540.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Duan G, Feng S. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1. Biochem Biophys Res Commun. 2015;459(3):367–373.
   PubMed Web of Science ®Google Scholar
• Zeng Q, Dai Y, Duan C, et al. Long noncoding RNA POU3F3 enhances cancer cell proliferation, migration and invasion in non-small cell lung cancer (adenocarcinoma) by downregulating microRNA-30d-5p. BMC Pulm Med. 2020;20(1):185.
   PubMed Web of Science ®Google Scholar
• Lu T, Wang R, Cai H, et al. Long non-coding RNA DLEU2 promotes the progression of esophageal cancer through miR-30e-5p/E2F7 axis. Biomed Pharmacothe. 2020;123:109650.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Qin H, Jiang B, et al. miR-30e-5p suppresses cell proliferation and migration in bladder cancer through regulating metadherin. J Cell Biochem. 2019;120(9):15924–15932.
   PubMed Web of Science ®Google Scholar
• Mullany LE, Herrick JS, Wolff RK, et al. MicroRNA-transcription factor interactions and their combined effect on target gene expression in colon cancer cases. Genes Chromosomes Cancer. 2018;57(4):192–202.
   PubMed Web of Science ®Google Scholar
• Tian R, Xu Y, Dou WW, et al. Bioinformatics analysis of microarray data to explore the key genes involved in HSF4 mutation-induced cataract. Int J Ophthalmol. 2018;11(6):910–917.
   PubMed Web of Science ®Google Scholar
• Fiorillo AA, Heier CR, Huang YF, et al. Estrogen receptor, inflammatory, and FOXO transcription factors regulate expression of myasthenia gravis-associated circulating microRNAs. Front Immunol. 2020;11:151.
   PubMed Web of Science ®Google Scholar
• Xing W, Xu WY, Chang L, et al. SP1-induced lncRNA LINC00689 overexpression contributes to osteosarcoma progression via the miR-655/SOX18 axis. Eur Rev Med Pharmacol Sci. 2020;24(5):2205–2217.
   PubMed Web of Science ®Google Scholar
• Hu XH, Dai J, Shang HL, et al. SP1-mediated upregulation of lncRNA ILF3-AS1 functions a ceRNA for miR-212 to contribute to osteosarcoma progression via modulation of SOX5. Biochem Biophys Res Commun. 2019;511(3):510–517.
   PubMed Web of Science ®Google Scholar
• Wang Z, Yang H. EMMPRIN, SP1 and microRNA-27a mediate physcion 8-O-β-glucopyranoside-induced apoptosis in osteosarcoma cells. Am J Cancer Res. 2016;6(6):1331–1344.
   PubMed Web of Science ®Google Scholar
• Gao Y, Luo X, Zhang J. Sp1-mediated up-regulation of lnc00152 promotes invasion and metastasis of retinoblastoma cells via the miR-30d/SOX9/ZEB2 pathway. Cell Oncol (Dordr). 2021;44(1):61–76.
   PubMed Web of Science ®Google Scholar
• Jin XM, Xu B, Zhang Y, et al. LncRNA SND1-IT1 accelerates the proliferation and migration of osteosarcoma via sponging miRNA-665 to upregulate POU2F1. Eur Rev Med Pharmacol Sci. 2019;23(22):9772–9780.
   PubMed Web of Science ®Google Scholar
• Li M, Wu J, Hu G, et al. Pathological matrix stiffness promotes cardiac fibroblast differentiation through the POU2F1 signaling pathway. Sci China Life Sci. 2021;64(2):242–254.
   PubMed Web of Science ®Google Scholar
• Kureel J, John AA, Prakash R, et al. MiR 376c inhibits osteoblastogenesis by targeting Wnt3 and ARF-GEF-1 -facilitated augmentation of beta-catenin transactivation. J Cell Biochem. 2018;119(4):3293–3303.
   PubMed Web of Science ®Google Scholar
• Jacques C, Tesfaye R, Lavaud M, et al. Implication of the p53-Related miR-34c, −125b, and −203 in the osteoblastic differentiation and the malignant transformation of bone sarcomas. Cells. 2020;9(4):9.
   Web of Science ®Google Scholar
• Tanaka K, Kawano M, Itonaga I, et al. Tumor suppressive microRNA-138 inhibits metastatic potential via the targeting of focal adhesion kinase in Ewing’s sarcoma cells. Int J Oncol. 2016;48(3):1135–1144.
   PubMed Web of Science ®Google Scholar
• Liu X, Liang Z, Gao K, et al. MicroRNA-128 inhibits EMT of human osteosarcoma cells by directly targeting integrin α2. Tumour Biol. 2016;37(6):7951–7957.
   PubMedGoogle Scholar
• Zhuyan J, Chen M, Zhu T, et al. Critical steps to tumor metastasis: alterations of tumor microenvironment and extracellular matrix in the formation of pre-metastatic and metastatic niche. Cell Biosci. 2020;10(1):89.
   PubMed Web of Science ®Google Scholar
• Kaczorowska A, Miękus N, Stefanowicz J, et al. Selected matrix metalloproteinases (MMP-2, MMP-7) and Their Inhibitor (TIMP-2) in adult and pediatric cancer. Diagnostics (Basel). 2020;10(8):10.
   Google Scholar
• Brooks J, Ramsey ML. Dermatofibrosarcoma Protuberans. In: StatPearls. Treasure Island (FL): StatPearls Publishing Copyright ©; 2021. StatPearls Publishing LLC., 2021.
   Google Scholar
• Bi S, Chai L, Yuan X, et al. MicroRNA-98 inhibits the cell proliferation of human hypertrophic scar fibroblasts via targeting Col1A1. Biol Res. 2017;50(1):22.
   PubMedGoogle Scholar
• Leask A A centralized communication network: recent insights into the role of the cancer associated fibroblast in the development of drug resistance in tumors. Seminars in cell & developmental biology 2020; 101:111–114.
   Google Scholar
• Tsai HC, Su HL, Huang CY, et al. CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d. Oncotarget. 2014;5(11):3800–3812.
   PubMedGoogle Scholar
• Gong C, Yang Z, Wu F, et al. miR-17 inhibits ovarian cancer cell peritoneal metastasis by targeting ITGA5 and ITGB1. Oncol Rep. 2016;36(4):2177–2183.
   PubMed Web of Science ®Google Scholar
• Jia J, Yin P, Han G, et al. MicroRNA-300 decreases cell viability, inhibits migration and promotes apoptosis of osteosarcoma cells via downregulation of Twist1. Mol Med Rep. 2017;16(3):3613–3618.
   PubMed Web of Science ®Google Scholar
• Sun X, Dai G, Yu L, et al. miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2. Sci Rep. 2018;8(1):606.
   PubMedGoogle Scholar
• Croset M, Pantano F, Kan CWS, et al. miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes. Cancer Res. 2018;78(18):5259–5273.
   PubMed Web of Science ®Google Scholar